Discovery of Highly Potent and Efficient CBP/p300 Degraders with Strong In Vivo Antitumor Activity.
Hu J, Xu H, Wu T, Zhang C, Shen H, Dong R, Hu Q, Xiang Q, Chai S, Luo G, Chen X, Huang Y, Zhao X, Peng C, Wu X, Lin B, Zhang Y, Xu Y.
Hu J, et al.
J Med Chem. 2024 May 9;67(9):6952-6986. doi: 10.1021/acs.jmedchem.3c02195. Epub 2024 Apr 22.
J Med Chem. 2024.
PMID: 38649304